Skip to main content
FinSpry Logo
FinSpry
TECH logo
TECH
(NASDAQ)
Bio-Techne Corporation
$55.61-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bio-Techne (TECH) Stock Price & Financial Analysis

Bio-Techne Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$55.46 - $58.56
52-Week High$72.16
52-Week Low$43.20
Open$58.14
Volume1.97M
Average Volume (3M)2.97M
Market Cap8.73B
Shares Outstanding156.94M
P/E Ratio (TTM)79.65
Forward P/E95.45
Price to Sales (P/S)7.21
Price to Book (P/B)4.19
EV/EBITDA34.57
Revenue (TTM)1.21B
Net Income (TTM)109.57M
Free Cash Flow (TTM)269.60M
EPS (TTM)$0.70
Profit Margin9.05%
Operating Margin12.70%
Return on Equity (ROE)5.25%
Debt to Equity0.14
50-Day MA$52.49
200-Day MA$57.50
52-Week Change11.47%
Annual Dividend$0.32
Dividend Yield0.58%
Payout Ratio45.71%
Last Dividend Ex-DateMay 18, 2026

Frequently Asked Questions About Bio-Techne

What is the current stock price for TECH?

As of the latest trading session, TECH stock trades at $55.61. The 52-week range is $43.20–$72.16, with a day range of $55.46–$58.56.

What is the P/E ratio for TECH?

Bio-Techne's trailing P/E ratio is 79.7, meaning investors pay $79.7 for every $1 of annual earnings. The forward P/E is 95.5, reflecting analyst expectations for future earnings. Bio-Techne operates in the Healthcare sector.

Does TECH pay dividends?

Yes, Bio-Techne pays a 0.58% annual dividend yield ($0.32 per share). The payout ratio is 45.7%. The last ex-dividend date was 2026-05-18.

What do analysts recommend for TECH?

Based on 12 analysts, the consensus for TECH is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TECH?

Bio-Techne's market capitalization is $8.73B, classifying it as a mid-cap company. Bio-Techne operates in the Healthcare sector within the Biotechnology industry.